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The Cromer blood group system consists of nine high-prevalence
and three low-prevalence antigens carried on decay-accelerating
factor (DAF). We recently described one of these Cromer high-
prevalence antigens,SERF, the absence of which was found in a Thai
woman. The lack of SERF antigen in this proband was associated
with a substitution of nucleotide 647C>T in exon 5 of DAF, which
is predicted to be a change of proline to leucine at amino acid
position 182 in short consensus repeat (SCR) 3 of DAF. This study
reports on PCR-RFLP analysis of the SERF allele with BstNI
restriction endonuclease on more than one thousand Thai blood
donor samples. One new donor homozygous (647T) and 21 donors
heterozygous (647C/T) for the SERF allele were found. Among this
cohort of random Thai blood donors, the SERF allele frequency was
1.1 percent. Thus, like other alleles in the Cromer blood group
system, SERF is found in a certain ethnic group.
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The antigens of the Cromer blood group system are
carried on decay-accelerating factor (DAF; CD55),
which is a member of the regulators of complement
activation family of proteins.1 DAF has four
homologous short consensus repeat (SCR) domains
followed by an O-glycosylated serine- and threonine-
rich region attached to a glycosylphosphatidylinositol
(GPI) membrane anchor.2 The Cromer blood group
system consists of nine high-prevalence and three low-
prevalence antigens.3,4 Each antigen, with the
exception of IFC, is associated with a single amino acid
change in DAF. The location of the various Cromer
antigens on DAF was accomplished by testing the
corresponding antibodies against stable transfectants
expressing full-length and deletion mutants of DAF.5
Tca/Tcb/Tcc, Esa, and WESa/WESb are located in SCR 1;
Dra and SERF are within SCR 3; and Cra, UMC, and GUTI
are within SCR 4.4–8 The Dr(a–) phenotype is
characterized by a single nucleotide substitution that is
predicted to change serine to leucine at position 165 of
DAF. This single nucleotide substitution exposes a
cryptic splice site that leads to aberrant RNA splicing,
causing a profound decrease in expression both of 
full-length RNA and of RBC-surface DAF, thus Cromer
antigens are very weakly expressed on Dr(a–) RBCs.9,10
RBCs of the Cromer null phenotype, known as Inab,
totally lack DAF expression, with more than one
mutation in the DAF gene reported.9,11–13
Interestingly, the absence of a high-prevalence
Cromer blood group antigen is restricted to a certain
ethnic group. The Cr(a–) and Tc(a–b+) phenotypes are
found predominantly in the Black population.1
Similarly, the Dr(a–) phenotype is restricted to Jews
originating from the Bukharan area of Uzbekistan9,14,15
and to the Japanese.16–18 The mutation associated with
the lack of the GUTI antigen has been found in 15
percent of Mapuche Indians in Chile.8 We recently
showed that the allele associated with an absence of
the SERF antigen was present in 2 percent of Thai
donors. The SERF polymorphism is associated with a
single nucleotide change of 647C>T in exon 5, which
is predicted to encode an amino acid change of proline
182 to leucine.4
This report describes a PCR-RFLP analysis for the
SERF allele in 1041 Thai blood donors.
Materials and Methods
Samples
Three milliliters of peripheral blood samples were
collected from each of 1041 healthy volunteer blood
donors at the National Blood Centre, Thai Red Cross
Society. Institutional Review Board (IRB) approval was
obtained.
Genomic DNA extraction from blood
Genomic DNA was extracted from the buffy coat
that was collected after centrifugation of the whole
blood at 10,000 rpm for 5 minutes. RBC lysis buffer of
155 mM NH4Cl, 10 mM KHCO3, and 0.1 mM EDTA, pH
7.4,was added; the tube was centrifuged at 10,000 rpm
for 10 minutes;and the supernatant was discarded. The
white blood cell pellets were resuspended in 200 µL TE
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buffer (25 mM Tris and 5 mM EDTA), and lysed by the
addition of 10% SDS and proteinase K at 37°C for 1 to
2 hours. DNA was purified by chloroform-isoamyl
alcohol extraction and precipitated by isopropanol at
–20°C.19 DNA was collected by centrifugation at
10,000 rpm at 4°C for 10 minutes, washed with cold
70% ethanol, and air-dried. DNA was solubilized in 
50 µL of 0.5X TE buffer at 60°C for 10 minutes and
stored at –20°C.
The quality and concentration of DNA was
determined by comparison with known concen-
trations of λDNA/HindIII on a 0.7% agarose gel.
Alternatively, the amount of DNA was measured by a
spectrophotometer, using the absorbance at 260 nm,
and calculated based on the definition that 1 OD260 of
dsDNA is equivalent to 50 µg/mL DNA.
PCR-RFLP analysis with BstNI
We used the PCR-RFLP assay previously described.4
In brief, we used the sense primer, SERF 5´
(5´gtgtagtaaatattttaagataataacc 3´) that is located in
intron 4, and the antisense primer, SERF 3´ (5´
cttacCTCTGCACTCTGGCACC 3´); the underlined C is
a deliberate A>C change) that is located in exon 5 and
extends 5 nucleotides into intron 5 (sequence data as
per Douglas M. Lublin, MD, verbal communication).
The primers were synthesized by Life Technologies,
Inc. (Gaithersburg,MD). Two microliters (equivalent to
0.1 µg) of DNA per reaction were amplified using 5 U
of Taq DNA polymerase (HotStarTaq, QIAGEN Inc.,
Valencia, CA) in a 50-µL reaction mixture containing
1.5 mM MgCl2, 1X PCR buffer, 0.2 mM dNTPs, and 100
ng sense and antisense primers. PCR amplification was
performed in a thermal cycler (9700, Perkin Elmer,
Norwalk, CT) as follows: 35 cycles of 94°C for 20
seconds,55°C for 20 seconds, and 72°C for 20 seconds,
followed by a final extension of 10 minutes at 72°C.
PCR products were analyzed on a 1.2% agarose gel and
then subjected to digestion with BstNI (New England
Biolabs, Beverly, MA) overnight and analyzed on 8%
polyacrylamide gel.
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Fig. 1. PCR-RFLP analysis using BstNI of DAF exon 5.
Lane M: Molecular weight 100 bp DNA ladder marker. Lane 1:
188 bp uncut PCR amplicon. Lane 2: The digested PCR amplicon
from a normal control DNA,which shows the 160 bp band. Lane
3: The digested PCR product of a sample, homozygous for the
mutation, with a band of 137 bp. Lane 4: The digested PCR
product from a sample, heterozygous for the mutation and wild-
type with bands of 160 bp and 137 bp. The 28 bp band
associated with wild-type and mutated alleles,and the 23-bp band
associated with the mutated allele ran off the gel and thus are not
visible. Fig. 2. Map of Thailand showing regions.
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Results
The resulting PCR product of 188 bp, when
digested with BstNI, demonstrated one of three
patterns (Fig. 1). Of the 1041 samples tested, which
includes the 100 Thai donor samples previously
reported,4 we found one homozygous sample (in
addition to the original proband) and 21 heterozygous
samples. This represents an allele frequency of 1.1
percent in the 1041 random Thai donors. The allele
was found in northern, eastern, and central regions,but
not in the southern region of Thailand (Fig. 2). The
region of origin was unknown for 35 of the donors.
The SERF-negative allele was not found in 50 samples
from the southern region. A summary of our findings
is given in Table 1.
Discussion
SERF is a high-prevalence antigen in the Cromer
blood group system and is associated with a proline
residue at position 182 in DAF. The lack of SERF
antigen on RBCs is associated with a single nucleotide
mutation (647C>T) in exon 5,predicting an amino acid
change (Pro182Leu) in the third SCR of DAF. Absence
of the SERF antigen was found in the original Thai
proband4 and in one additional donor in this study. In
the previous report,4 two heterozygous samples were
found in 100 random Thai donors. In this report, we
tested 941 additional blood donors and confirmed that
the mutated SERF allele has a frequency of 1.1 percent
in Thailand. Thus, a total of 23 individuals (21
heterozygous random donors, one homozygous
random donor, and the original proband) have been
found to have the SERF-negative allele. Taken together,
this represents an allele frequency of 1.2 percent
(25/2084 × 100).
The SERF– phenotype joins other ethnically
restricted Cromer phenotypes, the Cr(a–) and Tc(a–b+)
phenotypes that are found predominantly in Blacks1;
the Dr(a–) phenotype that is restricted to Jews
originating from the Bukharan area of Uzbekistan9,14,15
and to the Japanese17,18; and the mutation associated
with the GUTI antigen, which has only been found in
Mapuche Indians in Chile.8 The Cromer phenotypes
associated with certain ethnicities are summarized in
Table 2. It should be noted that these ethnic
associations have been determined by knowing the
ethnicity of antibody producers and not by extensive
testing in various ethnic groups.
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